腫瘤科
潘明駿 醫生
臨床副教授（名譽）
腫瘤學系，香港中文大學
研究範疇 <只提供英文版本>
- Prostate Cancer
- Genitourinary Cancer
- Radiotherapy
履歷概要 <只提供英文版本>
Dr Darren Poon is the Honorary Clinical Associate Professor at the Chinese University of Hong Kong and the Honorary Consultant in Clinical Oncology at both the Hong Kong Sanatorium & Hospital and Prince of Wales Hospital, Hong Kong. He also appointed as Honorary Clinical Associate Professor at the University of Hong Kong. He is the Associate Director of the Comprehensive Oncology Center,
Hong Kong Sanatorium & Hospital. Currently, he is the vice-president of Hong Kong Society of UroOncology (HKSUO). Dr. Poon’s main clinical interest is genitourinary (GU) cancer. Besides, he has several specialist areas of expertise, which include neuro-oncology, hepato-pancreatic cancer, and head and neck cancer. His research interests include image-guided radiotherapy, and stereotactic body radiotherapy (SBRT) as well as novel therapies for GU cancers. Dr Poon pioneered the use of SBRT in the treatment of prostate cancer in Hong Kong and is also the leading-pioneer in MRI-guided radiotherapy for prostate cancer in Asia-Pacific. He has published more than 100 original papers, scientific reviews, and abstracts in peer-reviewed journals and has co-authored the 10th edition of Fast Facts: Prostate Cancer. He is one of the expert panel members in the Advanced Prostate Cancer Consensus Conference (APCCC) from 2019 onwards, and the Asia Pacific Advanced Prostate Cancer Consensus Conference (APAC-APCCC) from 2020 onwards. He is also member of the scientific committee of Genitourinary tumours track at ESMO Asia Congress 2024 & 2025.
Dr Poon has been an invited speaker at local and regional, and international conferences and is currently involved in several clinical trials investigating new therapies for urothelial, bladder, renal and prostate cancers. Besides, he is the editorial board member of BMC Oncology, Chinese Clinical Oncology, as well as the topic editor of Frontier in Oncology.